Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
AstraZeneca Pharma India Limited
ASTRAZEN | NSE
8,453.00
INR109.50
1.31%
ASTRAZEN | NSE
Loading StockChartView...
About AstraZeneca Pharma India Limited
Sector
Healthcare
Industry
Drug Manufacturers-Specialty & Generic
Earnings date
31/03/2024
As of date
09/06/2026
Close
8,453.00
Open
8,370.00
High
8,550.00
Low
8,344.00
AstraZeneca Pharma India Limited a biopharmaceutical company manufactures distributes and markets pharmaceutical products in India and internationally. It manufactures and sells cardiovascular disease and diabetes medicines under the Brilinta Betaloc Crestor Forxiga Imdur Kombiglyze XR Onglyza Seloken XL Xigduo XR and QTERN brands; Respiratory medicines under the Symbicort and FASENRA brand names; and oncology medicines under the LYNPARZA Tagrisso Iressa Calquence Casodex Faslodex Zoladex and Arimidex brands. The company also offers products in the areas of renal metabolic and immunology diseases. It also provides clinical trial services. The company was incorporated in 1979 and is based in Bengaluru India. AstraZeneca Pharma India Limited is a subsidiary of AstraZeneca Pharmaceuticals AB.
View LessASTRAZEN | NSE
Risk
26.7
Sharpe
0.06
Luna's Score
60/100
Recommendation
Hold
Luna says (ASTRAZEN | NSE)
What's Working
Low 6-Month Volatility (<30%)
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Revenue Growth (> 10%)
What's not Working
Price Below SMA10D
High Short-term Volatility
Midcap (2B - 10B USD)
Rich in Valuation (Price to Book > 8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
29.2%1 month
26.7%3 months
28.6%6 months
23.9%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
197.18
Fwd. PE
-
Price to book
26.78
Debt to equity
0.01
Debt to assets
0.00
Ent. to EBITDA
124.38
Ent. to rev.
13.37
PEG
-
Other Fundamentals
EBITDA
1.54B
MarketCap
211.32B
MarketCap(USD)
2.22B
Div. yield
0.31
Op. margin
8.81
Erngs. growth
128.60
Rev. growth
31.20
Ret. on equity
24.84
Short ratio
-
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
873.50
Range1M
918.50
Range3M
1.60K
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.39
Price X volume
35.98M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 124.38 | 24.85 | Expensive |
| Ent. to Revenue | 13.37 | 11.40 | Par |
| PE Ratio | 197.18 | 51.36 | Expensive |
| Price to Book | 26.78 | 6.83 | Expensive |
| Dividend Yield | 0.31 | 0.52 | Poor |
| Std. Deviation (3M) | 28.62 | 42.17 | Lower Risk |
| Debt to Equity | 0.01 | 0.35 | Cheaper |
| Debt to Assets | 0.00 | 0.17 | Cheaper |
| Market Cap | 211.32B | 290.82B | Emerging |
